Intravascular thrombophlebitis related to the peripheral infusion of amiodarone and vancomycin

Western Journal of Nursing Research

Volumn 33, Issue 3, 2011, Pages 457-471

  Mowry, Jole' L ^a   Hartman, Laurie Shawn ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

adults; cardiovascular; nurses; statistical analysis; surgical

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIINFECTIVE AGENT; VANCOMYCIN;

ARTICLE; CHEMICALLY INDUCED DISORDER; HUMAN; THROMBOPHLEBITIS;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ANTI-BACTERIAL AGENTS; HUMANS; THROMBOPHLEBITIS; VANCOMYCIN;

EID: 79952427372     PISSN: 01939459     EISSN: 15528456     Source Type: Journal    
DOI: 10.1177/0193945910380212     Document Type: Article

References (22)

1. Antonelli, D., & Barzilay, J. (1983). Acute thrombophlebitis following IV amiodarone administration. Chest, 84, 120.
2. Aravanis, C., Papasteriades, E., & Steriotis, J. (1982). Acute thrombophlebitis due to the use of amiodarone. Chest, 82, 515-516.
3. Aljitawi, O., Shabaneh, B., & Whitaker, J. (2005). Bilateral upper extremity thrombophlebitis related to intravenous amiodarone: A case report. Southern Medical Journal, 98, 814-816.
4. Cohen, E., Dadashev, A., Drucker, M., Samra, Z., Rubinstein, E., & Garty, M. (2002). Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients. Journal of Antimicrobial Chemotherapy, 49, 155-160.
5. Creswell, L.L., Schuessler, R.B., Rosenbloom, M., & Cox, J.L. (1993). Hazards of postoperative atrial arrhythmias. Annals of Thoracic Surgery, 56, 539-549.
6. Elting, L.S., Rubenstein, E.B., Kurtin, D., Rolston, K.V.I., Fangtang, J., Martin, C.G.,et al.(1998). Mississippi mud in the 1990s: Risks and outcome of vancomycin-associated toxicity in general oncology practice. Cancer, 83, 2597-2607.
7. Hadaway, L.C. (2002). I.V. infiltration. Nursing, 32, 36-42.
8. Hadaway, L.C., & Chamallas, S.N. (2003). Vancomycin: New perspectives on an old drug. Journal of Infusion Nursing, 26, 278-284.
9. Hilleman, D.E., & Spinler, S.A. (2002). Conversion of recent-onset atrial fibrillation with intravenous amiodarone: A meta-analysis of randomized controlled trials. Pharmacotherapy, 22, 66-74.
10. Intravenous Nurses Society. (2000). Infusion nursing standards of practice. Journal of Intravenous Nursing, 23, S56-S58.
11. Kerin, N., Blevins, R., Rubenfire, M., Faital, K., & Householder, S. (1983). Acute thrombophlebitis following IV amiodarone administration. Chest, 84, 120.
12. Khanderia, U., Wagner, D., Walker, P., Woodcock, B., & Prager, R. (2008). Amiodarone for atrial fibrillation following cardiac surgery: Development of clinical practice guidelines at a university hospital, Clinical Cardiology, 31, 6-10.
13. Kreiss, Y., Sidi, Y., & Gur, H. (1999). Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: Experience in patients admitted to a general internal medicine department, Postgraduate Medical Journal, 75, 278-281.
14. Maki, D.G., & Ringer, M. (1991). Risk factors for infusion-related phlebitis with small peripheral venous catheters. Annals of Internal Medicine, 114, 845-854.
15. McKeown, P.P., & Gutterman, D. (2005). Executive summary: American college of chest physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest, 128, 1S-5S.
16. Mitchell, L.B., Exner, D.V., Wyse, D.G., Connolly, C.J., Prystai, G.D., & Bayes, A.J. (2005). Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPA-BEAR: A randomized controlled trial. JAMA, 294, 3093-3100.
17. Potter, M. (2004). Deliberative nursing process. In S. L. Peterson & T. S. Bredow (Eds.), Middle range theory (pp. 302-322). Philadelphia: Lippincott Williams & Wilkins.
18. Showkathali, R., Earley, M.J., & Sporton, S. (2006). Amiodarone induced Thrombophlebitis. Emergency Medicine Journal, 23, 660.
19. Shrivastava, R., Smith, B., Caskey, D., & Reddy, P. (2009). Atrial fibrillation after cardiac surgery: Does prophylactic therapy decrease adverse outcomes associated with atrial fibrillation. Journal of Intensive Care Medicine, 24, 18-25.
20. Vassallo, P., & Trohman, R.G. (2007). Prescribing amiodarone: An evidence-based review of clinical indications. JAMA, 298, 1312-1322.
21. Veloso, H.H., & De Paola, A.A.V. (2004). Thrombophlebitis: A common complication of amiodarone. American Family Physician, 70, 1448.
22. Ward, G.H., & Yalkowsky, S.H. (1993). Studies in thrombophlebitis VI: Dilution-induced precipitation of amiodarone HCL. Journal of Parenteral Science & Technology, 47, 161-165.